Payment & Shipping Terms:
|Specification:||36iu Per Vial||Model Number:||Hgh Cartridge|
Private label service available!
Safe customs clearance
Full refund if you are not happy about our product!
We also wholesale oil and tablets for bodybuilding with best prices.
Feel free to contact us about any product!
Genotropin Pfizer 12mg (36IU) Pfizer is the brand name of HGH or human GH produced synthetically and commonly used in people with GH deficiency. In most cases, the body naturally synthesizes adequate GH levels for health and well-being.
Genotropin is an injectable drug representing a synthetic HGH produced with recombinant DNA technology. It refers to the growth produced natively in animals. Among athletes and bodybuilders it is used to gain extra muscles and to burn the unnecessary fat in the human body. It also increases the energy levels, improves the skin texture and immune system functions. Genotropin helps the body to recover between workouts and posses the ability to increase calcium retention and to strengthen the mineralization of bones.
Treatment with GENOTROPIN for short stature should be discontinued when the epiphyses are fused.
Idiopathic Short Stature
Small for Gestational Age1
Dosing of Adult Patients :
Adult Growth Deficiency (GHD)
Either of two approaches to GENOTROPIN dosing may be followed: a non-weight based regimen or a weight based regimen.
Non-weight based — based on published consensus guidelines, a starting dose of approximately 0.2 mg/day (range, 0.15–0.30 mg/day) may be used without consideration of body weight. This dose can be increased gradually every 1–2 months by increments of approximately 0.1–0.2 mg/day, according to individual patient requirements based on the clinical response and serum insulin-like growth factor I (IGF-I) concentrations. The dose should be decreased as necessary on the basis of adverse events and/or serum IGF-I concentrations above the age- and gender-specific normal range. Maintenance dosages vary considerably from person to person, and between male and female patients.
Weight based — based on the dosing regimen used in the original adult GHD registration trials, the recommended dosage at the start of treatment is not more than 0.04 mg/kg/week. The dose may be increased according to individual patient requirements to not more than 0.08 mg/kg/week at 4–8 week intervals. Clinical response, side effects, and determination of age- and gender-adjusted serum IGF-I concentrations should be used as guidance in dose titration.
Contact Person: Mr. 855